ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 68 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,540 | +289.6% | 2,000 | 0.0% | 0.00% | – |
Q2 2023 | $652 | +65100.0% | 2,000 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $1 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1 | -100.0% | 2,000 | -33.3% | 0.00% | -50.0% |
Q3 2022 | $2,000 | -33.3% | 3,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,000 | -66.7% | 3,000 | 0.0% | 0.00% | -66.7% |
Q1 2022 | $9,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $9,000 | -30.8% | 3,000 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $13,000 | -27.8% | 3,000 | +50.0% | 0.01% | -30.8% |
Q4 2020 | $18,000 | 0.0% | 2,000 | 0.0% | 0.01% | -31.6% |
Q1 2020 | $18,000 | +200.0% | 2,000 | +100.0% | 0.02% | +280.0% |
Q4 2019 | $6,000 | -25.0% | 1,000 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $8,000 | -42.9% | 1,000 | 0.0% | 0.01% | -50.0% |
Q2 2019 | $14,000 | +180.0% | 1,000 | 0.0% | 0.01% | +140.0% |
Q1 2019 | $5,000 | +66.7% | 1,000 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $3,000 | -62.5% | 1,000 | 0.0% | 0.00% | -57.1% |
Q3 2018 | $8,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
Founders Capital Management | 2,000 | $18,000 | 0.01% |
King Wealth Management Group | 16,000 | $53,000 | 0.01% |
Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |